1079992-97-4

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 6-fluoro-2-methyl-3-nitrobenzoate is used as a building block for the production of various drugs and biologically active molecules. Its unique chemical structure allows it to be a key component in the synthesis of complex organic compounds.
Used in Organic Synthesis:
Methyl 6-fluoro-2-methyl-3-nitrobenzoate is used as a reagent in organic synthesis, particularly in the creation of more complex chemical compounds. Its versatile structure and functional groups make it a valuable component in the development of new chemical entities.
Used in Research Laboratories:
Methyl 6-fluoro-2-methyl-3-nitrobenzoate is used in research laboratories for the study and development of new chemical compounds and drug candidates. Its unique properties and reactivity make it a valuable tool in the exploration of novel chemical reactions and pathways.
Used in Chemical Manufacturing Facilities:
Methyl 6-fluoro-2-methyl-3-nitrobenzoate is used in chemical manufacturing facilities for the large-scale production of various drugs and biologically active molecules. Its importance in the pharmaceutical industry and organic synthesis makes it a key component in the manufacturing process.

Upstream product

• 1079992-96-3 (6-fluoro-2-methyl-3-nitrobenzoic acid) 
• 74-88-4 methyl iodide 
• 90259-27-1 2-fluoro-6-methylbenzoic acid 

Downstream Products

• 848678-60-4 3-amino-6-fluoro-2-methyl-benzoic acid methyl ester 

Relevant academic research and scientific papers

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS

Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal

BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s); R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); Xa and Xb are each C, N, O or S; Xc and Xd are each C or N; m is 0-2; n is 1-3; ring A is a 5-membered ring optionally having substituent(s); ring B is a 6-membered ring optionally having substituent(s); and ring C is a 3- to 5-membered ring optionally having substituent(s), provided that when Xa, Xc and Xd are each C, then Xb is N or S, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

HETEROAROMATIC UREAS WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)

Compounds of formula (I): are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).